Corpus ID: 74030145

Promising Cure to URTI Pandemics, Including the Avian Flu (H5N1): Has the Final Solution to the Coming Plagues Been Discovered? (Part II)

@inproceedings{Gordon2006PromisingCT,
  title={Promising Cure to URTI Pandemics, Including the Avian Flu (H5N1): Has the Final Solution to the Coming Plagues Been Discovered? (Part II)},
  author={E. Gordon and K. Holtorf},
  year={2006}
}
  • E. Gordon, K. Holtorf
  • Published 2006
  • Medicine
  • BACKGROUND: Recently Rentz (2003) published a convincing retrospective, peer-reviewed treatise on a highly advanced, effective and safe virotoxic oligodynamic silver (Ag+) hydrosol, making the case that it is the agent of choice to combat SARS.1 The works of Goetz (1940),2 Berger et al (1976),3 Simonetti et al (1992),4 Russel et al (1994),5 and Crocker and Grier (1998)6 collectively established that electrolytically produced oligodynamic Ag+ hydrosol provides the ideal speciation of bioactive… CONTINUE READING
    1 Citations

    Topics from this paper

    The silver lining: towards the responsible and limited usage of silver
    • 12

    References

    SHOWING 1-10 OF 76 REFERENCES
    Viral Pathogens and Severe Acute Respiratory Syndrome: Oligodynamic Ag+ for Direct Immune Intervention
    • 31
    • PDF
    Changes in circulating immune complexes during the Jarisch Herxheimer reaction in secondary syphilis
    • 12
    [Effect of silver compounds on viruses in water].
    • H. Mahnel, M. Schmidt
    • Chemistry, Medicine
    • Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. Serie B, Umwelthygiene, Krankenhaushygiene, Arbeitshygiene, praventive Medizin
    • 1986
    • 8
    Influenza virus infection of hamsters. A model for evaluating antiviral drugs
    • H. Renis
    • Biology, Medicine
    • Archives of Virology
    • 2005
    • 5
    Inactivation of Herpesvirus hominis Types 1 and 2 by Silver Nitrate In Vitro and In Vivo
    • 16
    • PDF
    Antimicrobial activity and action of silver.
    • 861
    Silver sulphadiazine: a comprehensive in vitro reassessment.
    • 58
    • PDF